Surgical management of primary hyperparathyroidism during pregnancy: a systematic review of the literature

Gynecol Endocrinol. 2021 Dec;37(12):1086-1095. doi: 10.1080/09513590.2021.1932801. Epub 2021 May 28.

Abstract

Objective: Gestational primary hyperparathyroidism (PHPT) is an endocrinological disorder with serious outcomes for both women and neonates. The aim of our study was to present the current evidence concerning the perioperative outcomes of pregnant women with PHPT who underwent parathyroidectomy during pregnancy.

Methods: A meticulous systematic review of the literature published before February 2020 and all studies which presented perioperative and pregnancy outcomes off pregnant women who underwent parathyroidectomy for PHPT, were included.

Results: A total of 53 were finally included, which reported 92 pregnant women who had parathyroidectomy during their pregnancy. A total of 46 patients were hospitalized due to significant complications of PHPT before their parathyroidectomy. With regards to surgical approach, 52.2% of patients underwent minimally invasive parathyroidectomy (MIP), while bilateral neck exploration (BNE) was 41.3% of cases. Only 4 women was not cured, whereas transient hypocalcemia was occurred in 18 patients. All cases proceeded to deliveries of healthy neonates, after their parathyroidectomy.

Conclusions: Parathyroidectomy during pregnancy is a safe and effective treatment option with minimum complications and probably should be considered as the treatment of choice in specific group of pregnant women with PHPT.

Keywords: Primary hyperparathyroidism; gestational hyperparathyroidism; parathyroidectomy; pregnancy.

Publication types

  • Systematic Review

MeSH terms

  • Female
  • Humans
  • Hyperparathyroidism, Primary / surgery*
  • Parathyroidectomy*
  • Pregnancy
  • Pregnancy Complications / surgery*
  • Treatment Outcome